KRYS: Krystal Biotech, Inc. 2020-05-14 08:00:10 Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB105 in Patients with TGM1-related Autosomal Recessive Congenital Ichthyosis (ARCI)
RARE: Ultragenyx Pharmaceutical Inc. 2020-05-13 16:01:10 Ultragenyx Announces Positive Longer-term Results from First Three Cohorts of Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
MYGN: Myriad Genetics, Inc. 2020-05-11 07:05:10 Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer
RDHL: RedHill Biopharma Ltd. 2020-05-08 07:00:10 RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.
AMGN: Amgen 2020-05-06 09:00:00 Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 ADVANCE Study In Mild-To-Moderate Plaque Psoriasis
AKBA: Akebia Therapeutics 2020-05-05 06:59:00 Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
TGTX: TG Therapeutics, Inc. 2020-05-05 07:00:10 TG Therapeutics Announces Positive Topline Results from the UNITY-CLL Phase 3 Study Evaluating the Combination of Umbralisib and Ublituximab (U2) for the Treatment of Patients with Chronic Lymphocytic Leukemia
MRKR: Marker Therapeutics, Inc. 2020-04-29 16:05:00 Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
BHC: Bausch Health Companies Inc. 2020-04-29 07:00:00 FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
AVDL: Avadel Pharmaceuticals plc 2020-04-27 07:00:10 Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy
AMPH: Amphastar Pharmaceuticals, Inc. 2020-04-27 06:00:10 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
PRGO: Perrigo Company plc 2020-04-06 08:30:00 Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren® Arthritis Pain
SNGX: Soligenix, Inc. 2020-03-19 06:00:00 Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
EYPT: EyePoint Pharmaceuticals, Inc. 2020-03-02 07:00:10 EyePoint Pharmaceuticals Announces Positive Topline 36-month Follow-up Data for Second Phase 3 Study of YUTIQ®
BHVN: Biohaven Pharmaceutical Holding Company Ltd. 2020-02-27 16:11:00 Biohaven's NURTEC(TM) ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults
ESPR: Esperion Therapeutics, Inc. 2020-02-26 17:30:10 Esperion Announces FDA Approval of the NEXLIZET™ (bempedoic acid and ezetimibe) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
IFRX: InflaRx N.V. 2020-02-26 07:30:10 InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
AVNS: Avanos Medical 2020-02-24 16:01:00 Avanos Medical, Inc. Announces FDA Clearance of its New, 80-Watt COOLIEF* Radiofrequency System for Neurological Lesion Procedures